Portal de investigación
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNTADOLESCENTS-2).
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
ELI LILLY AND COMPANY
Cita
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNTADOLESCENTS-2). (I8F-MC-GPIX). ELI LILLY AND COMPANY. 2024IP:FRANCISCA MORENO MACIÁN.